Hidemi Nakagawa

7PUBLICATIONS
20CO-AUTHORS
Photography, video and lens-based practiceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Traditional Chinese medicine and treatmentsPharmacogenomicsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 17, 2023
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study.

Akihiko Asahina, Yukari Okubo, Akimichi Morita

|Feb 25, 2021
Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64-week phase 3 study (reSURFACE 1).

Atsuyuki Igarashi, Hidemi Nakagawa, Akimichi Morita

|Feb 01, 2021
Long-term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5-year extension of a phase 3 study (reSURFACE 1).

Shinichi Imafuku, Hidemi Nakagawa, Atsuyuki Igarashi

|Nov 08, 2020
Relationship between serum trough levels and efficacy of brodalumab from a post hoc exploratory analysis of a Japanese study in patients with plaque psoriasis.

Yukie Yamaguchi, Yasumasa Kanai, Hiroki Kitabayashi

|Aug 01, 2020
Patient satisfaction and efficacy of calcipotriol plus betamethasone dipropionate gel in plaque psoriasis patients with poor adherence.

Hidetoshi Takahashi, Hiroyasu Katayama, Yuta Uwajima

|Feb 27, 2019
Relationship between the Degrees of Itch and Serum Lipocalin-2 Levels in Patients with Psoriasis.

Norie Aizawa, Yozo Ishiuji, Mitsutoshi Tominaga

Pageof 2

Frequent Collaborators

3 joint publications

Atsuyuki Igarashi

3 joint publications

Akimichi Morita

3 joint publications

Yukari Okubo

3 joint publications

Yayoi Tada